Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 4Breast Neoplasms 4Neoplasms 2Head and Neck Neoplasms 2Radiation Induced Xerostomia 1Radiation Fibrosis Syndrome 1Oral Ulcer 1Mucositis 1Mouth Neoplasms 1Lymphedema 1Graft vs Host Disease 1Cognitive Dysfunction 1

Interventions

Cyclophosphamide 16Mycophenolic Acid 13Tacrolimus 10fludarabine 9ruxolitinib 8Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6Sirolimus 6Melphalan 6Methotrexate 5Thiotepa 4ibrutinib 3Specimen Handling 3Cyclosporine 3Abatacept 3Stem Cell Transplantation 2Radiotherapy 2Hematopoietic Stem Cell Transplantation 2Clofarabine 2Biopsy 2vedolizumab 1tildrakizumab 1itacitinib 1blinatumomab 1belumosudil 1axatilimab 1Vorinostat 1Therapeutics 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Low-Level Light Therapy × 1 year × Clear all
NCT05675930 2026-05-22

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
44 enrolled

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡